tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

Immutep announces patient enrollment completed for EFTISARC-NEO Phase II trial
The FlyImmutep announces patient enrollment completed for EFTISARC-NEO Phase II trial
8d ago
IMMP
Immutep Completes Patient Enrolment for Key Phase II Cancer Trial
PremiumCompany Announcements
Immutep Completes Patient Enrolment for Key Phase II Cancer Trial
9d ago
Immutep completes patient enrollment for INSIGHT-003
PremiumThe Fly
Immutep completes patient enrollment for INSIGHT-003
24d ago
IMMP
Immutep Completes Enrolment for Promising INSIGHT-003 Cancer Trial
PremiumCompany Announcements
Immutep Completes Enrolment for Promising INSIGHT-003 Cancer Trial
25d ago
Immutep announces initial safety data from Phase I study on IMP761
PremiumThe Fly
Immutep announces initial safety data from Phase I study on IMP761
1M ago
IMMP
Immutep Ltd Announces Cessation of Performance Rights
PremiumCompany AnnouncementsImmutep Ltd Announces Cessation of Performance Rights
1M ago
Immutep Reveals Promising Data for IMP761 Trial
Premium
Company Announcements
Immutep Reveals Promising Data for IMP761 Trial
1M ago
Immutep, Monash University announce publication on human LAG-3
Premium
The Fly
Immutep, Monash University announce publication on human LAG-3
2M ago
IMMP
Immutep Ltd Reveals Key LAG-3 Binding Discovery
PremiumCompany Announcements
Immutep Ltd Reveals Key LAG-3 Binding Discovery
2M ago
Immutep announces results from Cohort B of TACTI-003 trial
PremiumThe Fly
Immutep announces results from Cohort B of TACTI-003 trial
2M ago
IMMP
Immutep’s Promising Trial Results in Cancer Therapy
PremiumCompany Announcements
Immutep’s Promising Trial Results in Cancer Therapy
2M ago
Immutep announces initiation of TACTI-004 Phase III trial
PremiumThe Fly
Immutep announces initiation of TACTI-004 Phase III trial
2M ago
IMMP
Immutep Ltd Director Increases Shareholding
PremiumCompany AnnouncementsImmutep Ltd Director Increases Shareholding
2M ago
Immutep Director Increases Shareholding with New Stock Conversion
Premium
Company Announcements
Immutep Director Increases Shareholding with New Stock Conversion
2M ago
Immutep Increases Director’s Stake with New Performance Rights
Premium
Company Announcements
Immutep Increases Director’s Stake with New Performance Rights
2M ago
Immutep Ltd Director Increases Stake with New Performance Rights
PremiumCompany Announcements
Immutep Ltd Director Increases Stake with New Performance Rights
2M ago
Immutep Initiates Phase III Trial for Lung Cancer
PremiumCompany Announcements
Immutep Initiates Phase III Trial for Lung Cancer
2M ago
Immutep Ltd Targets Lung Cancer with Promising Drug Trial
PremiumCompany Announcements
Immutep Ltd Targets Lung Cancer with Promising Drug Trial
2M ago
Immutep Limited Passes All AGM Resolutions
PremiumCompany Announcements
Immutep Limited Passes All AGM Resolutions
2M ago
Immutep Ltd Advances Efti in Cancer Treatment Trials
PremiumCompany AnnouncementsImmutep Ltd Advances Efti in Cancer Treatment Trials
2M ago
Immutep Ltd Sees Increased Stake from Regal Funds
Premium
Company Announcements
Immutep Ltd Sees Increased Stake from Regal Funds
2M ago
Immutep price target raised to $7 from $6 at Baird
Premium
The Fly
Immutep price target raised to $7 from $6 at Baird
3M ago
IMMP

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >